While immunotherapies have revolutionized cancer treatment, they come with significant challenges and side effects. Immune-related adverse events (irAEs) can affect various organs, leading to conditions such as colitis, hepatitis, and pneumonitis. Managing these side effects often requires immunosuppressive medications, which can complicate treatment. Additionally, not all patients respond to immunotherapy, and resistance mechanisms may develop.